Hepatit C (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hepatit C" in Swedish language version.

refsWebsite
Global rank Swedish rank
4th place
17th place
2nd place
14th place
838th place
621st place
1st place
1st place
218th place
532nd place
low place
low place
301st place
97th place
1,916th place
2,548th place
3,528th place
low place
4,581st place
4,108th place
low place
low place
195th place
182nd place
2,318th place
3,379th place
low place
low place

aafp.org

albawaba.com

www1.albawaba.com

casemedicine.com

cdc.gov

doi.org

dx.doi.org

georgetown.edu

ll.georgetown.edu

google.ca

books.google.ca

natap.org

nih.gov

ncbi.nlm.nih.gov

  • Houghton M (November 2009). ”The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatology 51 (5): sid. 939–48. doi:10.1016/j.jhep.2009.08.004. PMID 19781804. 
  • Rosen, HR (2011-06-23). ”Clinical practice. Chronic hepatitis C infection.”. The New England journal of medicine 364 (25): sid. 2429–38. PMID 21696309. Arkiverad från originalet den 2012-12-15. https://web.archive.org/web/20121215035840/http://www.casemedicine.com/ambulatory/Continuity%20Clinic/Clinic%20Articles/1)%20July/2)Week%20of%20July%2025th/chronic%20hep%20c.NEJM.pdf. Läst 30 augusti 2012. 
  • Maheshwari, A; Ray, S, Thuluvath, PJ (2008-07-26). ”Acute hepatitis C.”. Lancet 372 (9635): sid. 321–32. doi:10.1016/S0140-6736(08)61116-2. PMID 18657711. 
  • Wilkins, T; Malcolm, JK, Raina, D, Schade, RR (2010-06-01). ”Hepatitis C: diagnosis and treatment.”. American family physician 81 (11): sid. 1351–7. PMID 20521755. http://www.aafp.org/afp/2010/0601/p1351.html. 
  • Nelson, PK; Mathers, BM, Cowie, B, Hagan, H, Des Jarlais, D, Horyniak, D, Degenhardt, L (2011-08-13). ”Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.”. Lancet 378 (9791): sid. 571–83. doi:10.1016/S0140-6736(11)61097-0. PMID 21802134. 
  • Mueller, S; Millonig, G, Seitz, HK (2009-07-28). ”Alcoholic liver disease and hepatitis C: a frequently underestimated combination.”. World journal of gastroenterology : WJG 15 (28): sid. 3462–71. PMID 19630099. 
  • Alter, MJ (2007-05-07). ”Epidemiology of hepatitis C virus infection.”. World journal of gastroenterology : WJG 13 (17): sid. 2436–41. PMID 17552026. 
  • Ozaras, R; Tahan, V (2009 Apr). ”Acute hepatitis C: prevention and treatment.”. Expert review of anti-infective therapy 7 (3): sid. 351–61. PMID 19344247. 
  • Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). ”Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Disease 39 (1): sid. 2–17. doi:10.1016/j.dld.2006.06.008. PMID 16884964. 
  • Louie, KS; Micallef, JM, Pimenta, JM, Forssen, UM (2011 Jan). ”Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.”. Journal of viral hepatitis 18 (1): sid. 1–7. PMID 20796208. 
  • Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (December 2011). ”An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int.. doi:10.1111/j.1478-3231.2011.02684.x. PMID 22142261. 
  • Maheshwari, A; Thuluvath, PJ (2010 Feb). ”Management of acute hepatitis C.”. Clinics in liver disease 14 (1): sid. 169–76; x. PMID 20123448. 
  • Pondé, RA; Mikhaĭlova, A (2011 Feb). ”Hidden hazards of HCV transmission.”. Medical microbiology and immunology 200 (1): sid. 7–11. PMID 20461405. 
  • Xia, X; Luo, J, Bai, J, Yu, R (2008 Oct). ”Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public health 122 (10): sid. 990–1003. doi:10.1016/j.puhe.2008.01.014. PMID 18486955. 
  • Imperial, JC (2010 Jun). ”Chronic hepatitis C in the state prison system: insights into the problems and possible solutions.”. Expert review of gastroenterology & hepatology 4 (3): sid. 355–64. PMID 20528122. 
  • Vescio, MF; Longo, B, Babudieri, S, Starnini, G, Carbonara, S, Rezza, G, Monarca, R (2008 Apr). ”Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.”. Journal of epidemiology and community health 62 (4): sid. 305–13. PMID 18339822. 
  • Tohme RA, Holmberg SD (June 2010). ”Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatology 52 (4): sid. 1497–505. doi:10.1002/hep.23808. PMID 20635398. 
  • Jafari, S; Copes, R, Baharlou, S, Etminan, M, Buxton, J (2010 Nov). ”Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.”. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 14 (11): sid. e928-40. PMID 20678951. http://natap.org/2010/HCV/tatoohcv.pdf. 
  • Lock G, Dirscherl M, Obermeier F, et al. (September 2006). ”Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat. 13 (9): sid. 571–3. doi:10.1111/j.1365-2893.2006.00735.x. PMID 16907842. 
  • Lam, NC; Gotsch, PB, Langan, RC (2010-11-15). ”Caring for pregnant women and newborns with hepatitis B or C.”. American family physician 82 (10): sid. 1225–9. PMID 21121533. 
  • Mast EE (2004). ”Mother-to-infant hepatitis C virus transmission and breastfeeding”. Advances in Experimental Medicine and Biology 554: sid. 211–6. PMID 15384578. 
  • Senadhi, V (2011 Jul). ”A paradigm shift in the outpatient approach to liver function tests.”. Southern medical journal 104 (7): sid. 521–5. PMID 21886053. 
  • Halliday, J; Klenerman, P, Barnes, E (2011 May). ”Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccines 10 (5): sid. 659–72. doi:10.1586/erv.11.55. PMID 21604986. 
  • Hagan, H; Pouget, ER, Des Jarlais, DC (2011-07-01). ”A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.”. The Journal of infectious diseases 204 (1): sid. 74–83. PMID 21628661. 
  • Torresi, J; Johnson, D, Wedemeyer, H (2011 Jun). ”Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatology 54 (6): sid. 1273–85. doi:10.1016/j.jhep.2010.09.040. PMID 21236312. 
  • Ilyas, JA; Vierling, JM (2011 Aug). ”An overview of emerging therapies for the treatment of chronic hepatitis C.”. Clinics in liver disease 15 (3): sid. 515–36. PMID 21867934. 
  • Foote BS, Spooner LM, Belliveau PP (September 2011). ”Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother 45 (9): sid. 1085–93. doi:10.1345/aph.1P744. PMID 21828346. 
  • Smith LS, Nelson M, Naik S, Woten J (May 2011). ”Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother 45 (5): sid. 639–48. doi:10.1345/aph.1P430. PMID 21558488. 
  • Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (October 2011). ”An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases”. Hepatology 54 (4): sid. 1433–44. doi:10.1002/hep.24641. PMID 21898493. 
  • Alavian SM, Tabatabaei SV (April 2010). ”Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat. 17 (4): sid. 236–44. doi:10.1111/j.1365-2893.2009.01170.x. PMID 19638104. 
  • Liu, J; Manheimer, E, Tsutani, K, Gluud, C (2003 Mar). ”Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.”. The American journal of gastroenterology 98 (3): sid. 538–44. PMID 12650784. 
  • Rambaldi, A; Jacobs, BP, Gluud, C (2007-10-17). ”Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.”. Cochrane database of systematic reviews (Online) (4): sid. CD003620. PMID 17943794. 
  • Fung J, Lai CL, Hung I, et al. (September 2008). ”Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseases 198 (6): sid. 808–12. doi:10.1086/591252. PMID 18657036. 
  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). ”Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Science 244 (4902): sid. 359–62. doi:10.1126/science.2523562. PMID 2523562. 
  • Kuo G, Choo QL, Alter HJ, et al. (April 1989). ”An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Science 244 (4902): sid. 362–4. doi:10.1126/science.2496467. PMID 2496467. 
  • Eurosurveillance editorial, team (2011-07-28). ”World Hepatitis Day 2011.”. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 16 (30). PMID 21813077. 
  • Wong, JB (2006). ”Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.”. PharmacoEconomics 24 (7): sid. 661–72. PMID 16802842. 
  • Ahn, J; Flamm, SL (2011 Aug). ”Hepatitis C therapy: other players in the game”. Clinics in liver disease 15 (3): sid. 641–56. doi:10.1016/j.cld.2011.05.008. PMID 21867942. 
  • Vermehren, J; Sarrazin, C (2011 Feb). ”New HCV therapies on the horizon.”. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 17 (2): sid. 122–34. PMID 21087349. 

nccam.nih.gov

nobelprize.org

phac-aspc.gc.ca

va.gov

hepatitis.va.gov

web.archive.org

who.int